Replies to post #113858 on Biotech Values

[DewDiligence]

…but likely PFE will terminate some promising partnerships, and if the stocks react badly there might be a buying opportunity.

Perhaps; however, I was thinking PFE is more likely to try to sublicense out the stuff it no longer wants the way NVS did with Iloperidone.

[jq1234]

Here is PFE pipeline. Most of the cut I can see are from Allergy/Respiratory.


http://www.pfizer.com/files/research/pipeline/2010_0927/pipeline_2010_0927.pdf